Stockreport

Genmab Announces Financial Results for the First Quarter of 2019

GENMAB A/S  (GMXAY) 
NASDAQ:AMEX Investor Relations: ir.genmab.com
PDF May 8, 2019; Copenhagen, Denmark;  Interim Report for the First Quarter Ended March 31, 2019 Highlights Regulatory applications for daratumumab in combination with [Read more]